Overcoming Regulatory & Operational Hurdles to Provide Patients with Access to Life Changing Therapeutics
Welcome to the 4th Operationalize Expanded Access Programs Summit
Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise.
Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading and new companies that are immersing themselves in this evolving field of opportunity and life-changing support.
Reunite with 120+ industry experts setting up and leading EAPs at the 4th Operationalize Expanded Access Programs Summit and gain practical take aways on how to construct a reliable system, define a clear exit strategy, understand updated local and global regulations, and determine the role of real-world data to optimize the operationalization of your EAP.
Don’t miss out on your opportunity to be amongst physicians, patients and passionate EAP and clinical supply experts from Novartis, Daiichi Sankyo, GSK, AstraZeneca, Gilead, Biogen, Sanofi, Eli Lilly, Regeneron, and many more to discover novel strategies in overcoming operational hurdles and deliver life-saving treatments to patients more efficiently.
World-Class Speaker Faculty Includes:
Elif Oral
Professor - Department of Internal Medicine, Division of Metabolism Endocrinology and Diabetes (MEND)
University of Michigan Health System
Companies Attending:
Join the Meeting to Hear From:
Ramona Reichenbach, Head of Managed Access Center of Excellence at Novartis and Elif Oral, Professor at the University of Michigan as they delve into physicians’ pain points, real world data collection and patient consent and assent
Irfan Mohammed, Director, Chemistry, Manufacturing & Controls Team Lead Product Development & Clinical Supply at Alexion, AstraZeneca Rare to ensure labelling consistency and compliance across the supply chain and review multinational labelling requirements
Katie Bowen, Expanded Access Coordinator at GSK to highlight practical strategies and important factors to consider to successfully deliver a project in the Middle East
Jasmina Ahrens, Expanded Access Coordinator at GSK to highlight practical strategies and important factors to consider to successfully deliver a project in the Middle East
Why Attend:
Looking to network with likeminded experts in Early Access?
Engross yourself in stimulating conversations with the brightest minds with 10+ hours of networking opportunities including speed networking, panel discussions and roundtables across all 3 days of the conference
Looking to hear novels strategies to improve programs?
Hear from experts at Eli Lilly, Biogen, Novartis, Regeneron, University of Michigan, Alexion, Sanofi and more on constructing a reliable system to manage requests, streamlining the labelling process, understanding physicians’ and patients’ experiences, and opening programs in regions with less established regulations.
Looking to meet solution providers to support your programs?
Early Access Care, Inceptua Early Access, MedaSystems, Durbin, myTomorrows, Almac Clinical Services, Bionical Emas and BAP Pharma will all be there to offer their support with identifying patients, collecting Real-World data, designing clinical trials, scaling programs and more.
Our Partners:
Previous Attendees Said:
Bring Your Team
10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5 or more delegates
*Please note that discounts are only valid when three or more delegates from one company book and pay at the same time. Discounts cannot be used in conjunction with any other offer or discount. Only one discount offer may be applied to the current pricing rate. If you are interested in bringing your team, please enquire here: info@hansonwade.com